Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico.

Autor: Bednar EM; Cancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA embednar@mdanderson.org., Paiz KA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Soares Dias De Souza AP; Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, Brazil., Oliveira G; Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, Brazil., Andrade CEEMDC; Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, Brazil., Gallardo L; Clinical Research, Instituto Nacional de Cancerologia, Mexico City, Mexico., Rubio-Cordero J; Clinical Research, Instituto Nacional de Cancerologia, Mexico City, Mexico., Cantu-de-León D; Clinical Research, Instituto Nacional de Cancerologia, Mexico City, Mexico., Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Jul 01; Vol. 34 (7), pp. 1020-1026. Date of Electronic Publication: 2024 Jul 01.